First, exposure to AHMs was defined based on prescription data, which cannot confirm whether the medications were dispensed or taken
The medication comes from licensed 503A compounding pharmacies, requires no insurance or membership, and qualifies for HSA/FSA savings
As Dermatologist Katherine Armour, a Melbourne-based skin expert, says, "There is often a change in the appearance of many of their moles, such that it can be difficult to detect melanomas or sometimes, clinically, for us to exclude melanoma." Melanotan is classified as an unapproved product by Australias Therapeutic Goods Administration (TGA)
Reported or plausible effects discussed by users and in limited literature include injection-site irritation (if used by injection), headache, nausea, fatigue, lightheadedness, and changes in sleep